Skip to contentA
Accendra Health Inc
A
ACHAccendra Health Inc Q2 2023 · 10-Q
Revenue$2.56B$2.56B+2.5% vs Q2 2022 Net Income-$28.24M-$28.24MN/M vs Q2 2022 EPS Diluted-$0.37-$0.37N/M vs Q2 2022 Gross Profit$519,432,000−2.5% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Accendra Health Inc · CIK 75252 · Engraved from SEC EDGAR
Operating Cash Flowderived$313,112,000+248.6% Free Cash Flowderived$266,512,000+616.5% Margins · derivedGross margin20.3%−1.0 pt vs Q2 2022
Operating margin0.4%−2.6 pt vs Q2 2022
Net margin-1.1%−2.2 pt vs Q2 2022
ended Jun 30, 2023 · filed Aug 4, 2023 · 35 d after period end